{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:02:05Z","timestamp":1790283725767,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016027","name":"NYU Grossman School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hrthm.2026.02.030","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:58:39Z","timestamp":1772096319000},"page":"e1584-e1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy"],"prefix":"10.1016","volume":"23","author":[{"given":"Xianming","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Davidsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gencarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah D.","family":"Ascheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Delmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-9939","authenticated-orcid":false,"given":"Marina","family":"Cerrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.02.030_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","article-title":"Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: JACC state-of-the-art review","volume":"72","author":"Gandjbakhch","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","article-title":"Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy","volume":"2","author":"Kyriakopoulou","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2026.02.030_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s43856-024-00450-w","article-title":"AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy","volume":"4","author":"Wu","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.hrthm.2026.02.030_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004305","article-title":"AAV-mediated delivery of Plakophilin-2a arrests progression of arrhythmogenic right ventricular cardiomyopathy in murine hearts: preclinical evidence supporting gene therapy in humans","volume":"17","author":"van Opbergen","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hrthm.2026.02.030_bib5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s44161-023-00370-3","article-title":"Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics","volume":"2","author":"Bradford","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2026.02.030_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib7","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1096\/fj.202001246RR","article-title":"Time-restricted feeding alleviates cardiac dysfunction induced by simulated microgravity via restoring cardiac FGF21 signaling","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.hrthm.2026.02.030_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and cardiac physiopathology","volume":"6","author":"Planavila","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.hrthm.2026.02.030_bib9","article-title":"High-Level serum fibroblast growth factor 21 concentration is closely associated with an increased risk of cardiovascular diseases: a systematic review and Meta-Analysis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.02.030_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep33953","article-title":"Circulating fibroblast growth factor 21 is associated with diastolic dysfunction in heart failure patients with preserved ejection fraction","volume":"6","author":"Chou","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2026.02.030_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure","volume":"28","author":"Tucker","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hrthm.2026.02.030_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087102","article-title":"Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2026.02.030_bib13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2026.02.030_bib14","first-page":"19","article-title":"Hepatic hormone FGF21 and its analogues in clinical trials","volume":"8","author":"Shao","year":"2022","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.hrthm.2026.02.030_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.hrthm.2026.02.030_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A Long-Acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.hrthm.2026.02.030_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.hrthm.2026.02.030_bib18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s12035-022-02741-6","article-title":"Neuroprotective effect of lentivirus-mediated FGF21 gene delivery in experimental Alzheimer\u2019s disease is augmented when concerted with rapamycin","volume":"59","author":"Kakoty","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41467-017-00127-0","article-title":"Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm","volume":"8","author":"Cerrone","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2026.02.030_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.122.060454","article-title":"Loss of nuclear envelope integrity and increased oxidant production cause DNA damage in adult hearts deficient in PKP2: a molecular substrate of ARVC","volume":"146","author":"P\u00e9rez-Hern\u00e1ndez","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.02.030_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.hrthm.2026.02.030_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008910","article-title":"FGF21 (fibroblast growth factor 21) defines a potential cardiohepatic signaling circuit in end-stage heart failure","volume":"15","author":"Sommakia","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2026.02.030_bib23","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.hrthm.2026.02.030_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2016.05.026","article-title":"Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-\u03baB signaling pathway","volume":"38","author":"Yu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib25","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-015-3630-8","article-title":"Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1\/2-dependent signalling pathway","volume":"58","author":"Zhang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.hrthm.2026.02.030_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41419-023-05842-9","article-title":"FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hrthm.2026.02.030_bib27","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fphys.2019.01496","article-title":"Mitochondrial dysfunction as substrate for arrhythmogenic cardiomyopathy: a search for new disease mechanisms","volume":"10","author":"van Opbergen","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib28","article-title":"Hot phase episodes in arrhythmogenic cardiomyopathy: more than just a desmoplakin issue?","author":"Martini","year":"2025","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.02.030_bib29","doi-asserted-by":"crossref","unstructured":"Penna VR, Amrute JM, Engel M, et al. Interleukin-1\u03b2 drives disease progression in arrhythmogenic cardiomyopathy. bioRxiv. Preprint. 2024:2024.12.11.628020.","DOI":"10.1101\/2024.12.11.628020"},{"key":"10.1016\/j.hrthm.2026.02.030_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.20517\/jca.2022.34","article-title":"Panoptosis is a prominent feature of desmoplakin cardiomyopathy","volume":"3","author":"Olcum","year":"2023","journal-title":"J Cardiovasc Aging"},{"key":"10.1016\/j.hrthm.2026.02.030_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.623190","article-title":"Transcriptomic coupling of PKP2 with inflammatory and immune pathways endogenous to adult cardiac myocytes","volume":"11","author":"P\u00e9rez-Hern\u00e1ndez","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.02.030_bib32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.119.039710","article-title":"Disruption of Ca2+I homeostasis and connexin 43 hemichannel function in the right ventricle precedes overt arrhythmogenic cardiomyopathy in Plakophilin-2-Deficient mice","volume":"140","author":"Kim","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.02.030_bib33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1161\/CIRCULATIONAHA.121.057757","article-title":"Exercise causes arrhythmogenic remodeling of intracellular calcium dynamics in Plakophilin-2-Deficient hearts","volume":"145","author":"van Opbergen","year":"2022","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:36:19Z","timestamp":1790282179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1547527126001530"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.02.030","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}